Becton, Dickinson & Co. (BDX)
200.43
+2.03
(+1.02%)
USD |
NYSE |
Dec 11, 16:00
200.45
+0.02
(+0.01%)
Pre-Market: 20:00
Becton, Dickinson Research and Development Expense (Quarterly): 322.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| ResMed, Inc. | 87.32M |
| West Pharmaceutical Services, Inc. | 17.10M |
| Solventum Corp. | 183.00M |
| Accuray, Inc. | 11.27M |